Yael R. Nobel, MD, MS
About Yael R. Nobel, MD, MS:
Yael R. Nobel, MD, MS is a transplant hepatologist and physician-scientist at Columbia University Irving Medical Center. She earned her BA in Chemistry with a minor in Global Health and Health Policy from Princeton University prior to attending medical school at the University of Pennsylvania School of Medicine. She completed her residency in Internal Medicine at NewYork-Presbyterian Columbia University Irving Medical Center, where she also served as a Chief Resident. She then completed her fellowship in Gastroenterology at NYP Columbia and her advanced training in Transplant Hepatology at NYP Columbia/Cornell.
Dr. Nobel’s clinical practice is focused on the diagnosis and management of patients with liver disease, including autoimmune liver diseases, viral hepatitis, metabolic dysfunction-associated steatotic liver disease, alcohol-associated liver disease, and liver cancer. As a transplant hepatologist, she has expertise in the care of patients before and after liver transplantation.
Dr. Nobel completed additional research training through an NIH T32 research fellowship at NYP Columbia and a Masters of Science (MS) in Biostatistics in the Patient-Oriented Research track from the Columbia University Mailman School of Public Health. Her research focuses on connections between intestinal bacteria and liver inflammation. Dr. Nobel’s work to date has been supported by grants from the American Association for the Study of Liver Diseases and the American College of Gastroenterology.
Expertise:
Honors:
Advanced/Transplant Hepatology Fellow Award, American Association for the Study of Liver Diseases (AASLD), 2023
Poster of Distinction, AASLD Liver Meeting, 2023
Presidential Poster Award, American College of Gastroenterology(ACG) Annual Meeting, 2023
Academic Skills Workshop, AASLD-AGA (American Gastroenterological Association), 2022
ACG Young Physician Leadership Scholars Program, 2021
Early Career Investigator Certificate of Recognition, Digestive Disease Week (DDW) Annual Meeting, 2017
Edward Raffensperger Research Prize in Gastroenterology, University of Pennsylvania School of Medicine, 2015
Herbert and Faye Moskowitz Prize in Clinical Epidemiology Research, University of Pennsylvania School of Medicine, 2015
Joel Gordon Miller Award (Most Significant Contribution to Student Body), University of Pennsylvania School of Medicine, 2015
Medical Scholars Award, Infectious Diseases Society of America (IDSA), 2013
Kass Award, IDSA Annual Meeting, 2011
Rochelle Hirschhorn Award, New York University Department of Medicine Research Day, 2011
Malcolm H. Chisholm Inorganic Chemistry Prize, Princeton University, 2010
Appointments:
Education:
New Patients:
Locations
Primary Locations:
CUIMC/Presbyterian Hospital and Vanderbilt Clinic
622 West 168th Street
New York, NY 10032
- For new and current patient appointments, call:
- (212) 305-0914
Insurances:
Please contact the doctor's office directly to verify that your particular insurance is accepted.
Publications:
Nobel YR, Boike J, Mazumder N, Thornburg B, Hoffman R, Kolli K, Fallon M, Lai J, Morelli G, Spengler E, Said A, Desai A, Paul S, Goel A, Hu K, Frenette C, Gregory D, Padilla C, Zhang Y, Vanwagner L+, Verna EC+. Predictors of Long-Term Clinical Outcomes after TIPS: An ALTA Group Study. Hepatology (2024) accepted ahead of print. +Co-senior authors.
Kaplan A, Lee-Riddle GS, Nobel Y, Dove L, Shenoy A, Rosenblatt R, Samstein B, Emond JC, Brown RS. National survey of second opinions for hospitalized patients in need of liver transplantation. Liver Transpl (2023) 29:1264-71.
Sehgal P, Su S, Zech J, Nobel Y, Luk L, Economou I, Shen B, Lewis JD, Freedberg DE. Visceral adiposity independently predicts time to flare in inflammatory bowel disease but body mass index does not. Inflammatory Bowel Diseases (2023) 30:594-601.
Sharma R, Schluger A, Ahmed FS, Nobel YR, Guo X, Zhao B, Verna EC. Visceral adiposity in cirrhosis: association with disease severity and impact of liver transplantation. Hepatology Communications (2023) 7:e0113.
Ching CK, Nobel YR, Pereira MR, Verna EC. The role of gastrointestinal pathogen PCR testing in liver transplant recipients hospitalized with diarrhea. Transplant Infectious Diseases (2022) 24:e13873.
Nobel YR, Rosenberg F, Park H, Freedberg DE, Blaser MJ, Green PHR, Uhlemann AC, Lebwohl B. Lack of effect of gluten challenge on fecal microbiome in patients with celiac disease and non-celiac gluten sensitivity. Clinical and Translational Gastroenterology (2021) 12:e00441.
Nobel YR, Su SH, Anderson MR, Luk L, Small-Saunders JL, Reyes-Soffer G, Gallagher D, Freedberg DE. Relationship between body composition and death in patients with COVID-19 differs based on the presence of gastrointestinal symptoms. Digestive Diseases and Sciences (2022) 67:4484-91.
Miller EH, Annavajhala M, Chong AM, Park H, Nobel YR, Soroush A, Blackett JW, Phipps MM, Freedberg DE, Zucker J, Sano ED, Uhlemann AC, Abrams JA. Oral microbiome alterations and SARS-CoV-2 saliva viral load in patients with COVID-19. Microbiology Spectrum (2021) 9:e0005521.
Anderson MR, Geleris J Anderson DR, Zucker J, Nobel YR, Freedberg D, Small-Saunders J, Rajagopalan KN, Greendyk R, Chae S, Natarajan K, Roh D, Edwin E, Gallagher D, Podolanczuk A, Barr RG, Ferrante AW, Baldwin MR. Body mass index and risk of intubation or death in SARS-CoV-2 infection: a retrospective cohort study. Annals of Internal Medicine (2020) 173:782-790.
Nobel YR, Phipps M, Zucker J, Lebwohl B, Wang TC, Sobieszczyk ME, Freedberg DE. Gastrointestinal symptoms and Coronavirus Disease 2019: Case-control study from the United States. Gastroenterology (2020) 159:373-375.
Snider EJ, Compres G, Freedberg DE, Khiabanian H, Nobel YR, Stump S, Uhlemann AC, Lightdale CJ, Abrams JA. Alterations to the esophageal microbiome associated with progression from Barrett’s esophagus to esophageal adenocarcinoma. Cancer Epidemiology, Biomarkers & Prevention (2019) 28:1687-1693.
Nobel YR, Snider EJ, Compres G, Freedberg DE, Khiabanian H, Lightdale CJ, Toussaint NC, Abrams JA. Increasing dietary fiber intake is associated with a distinct esophageal microbiome. Clinical and Translational Gastroenterology (2018) 9:199.
Axelrad JE, Joelson A, Nobel Y, Whittier S, Lawlor G, Riddle MS, Green PHR, Lebwohl B. The distribution of enteric infections utilizing stool microbial polymerase chain reaction testing in clinical practice. Digestive Diseases and Sciences (2018) 63:1900-1909.
Snider EJ, Compres G, Freedberg DE, Giddins MJ, Khiabanian H, Lightdale CJ, Nobel YR, Toussaint NC, Uhleman AC, Abrams JA. Barrett’s esophagus is associated with an altered oral microbiome. Clinical and Translational Gastroenterology (2017) 9:135.
Nobel YR, Axelrad J, Lewis SK, Whittier S, Lawlor G, Lichtiger S, Green PHR, Lebwohl B. Stool PCR for gastrointestinal pathogens in patients with and without intestinal immune-mediated intestinal diseases. Digestive Diseases and Sciences (2018) 63:996-1002.
Lebwohl B, Nobel YR, Green PHR, Blaser MJ, Ludvigsson JF. Risk of Clostridium difficile infection in patients with celiac disease: a population-based study. American Journal of Gastroenterology (2017) 112:1878-1884.
Axelrad JE, Joelson A, Nobel Y, Lawlor G, Green PHR, Lichtiger S, Lebwohl B. Enteric infection in relapse of inflammatory bowel disease: the utility of stool microbial PCR testing. Inflammatory Bowel Diseases (2017) 23:1034-1039.
Nobel YR+, Cox LM+, Kirigin FF, Bokulich NA, Yamanishi S, Teitler I, Chung J, Sohn J, Barber C, Goldfarb DS, Raju K, Abubucker S, Zhou Y, Ruiz VE, Li H, Mitreva M, Alekseyenko AV, Weinstock GM, Sodergren E, Blaser MJ. Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment. Nature Communications (2015) 6:7486. +Contributed equally.
Nobel YR, Goldberg DS. Variable use of MELD exception points in patients with neuroendocrine tumors metastatic to the liver and its impact on patient outcomes. Transplantation (2015) 99:2341-2346.
Nobel YR, Forde KA, Wood L, Cartiera K, Munoz-Abraham AS, Yoo PS, Abt PL, Goldberg DS. Racial and ethnic disparities in access to and utilization of living donor liver transplants. Liver Transplantation (2015) 21:904-913.
*Perreault G, Ching C, Nobel YR. COVID-19 in patients with liver disease and liver transplant: clinical implications, prevention, and management. Therapeutic Advances in Gastroenterology (2023) 16:17562848231188586.
Nobel YR, Phipps M, Verna EC. COVID-19 and effect on liver transplant. Current Treatment Options in Gastroenterology (2021) 19:483-499.
Nobel YR, Stier K, Krishnareddy S. STAT signaling in the intestine. Book: Postler TS, Galluzzi L (Eds.) International Review of Cell and Molecular Biology: Signal Transduction in Cancer and Immunity Elsevier, Amsterdam, Netherlands (2021) 361:1-20.
Singh A, Nobel Y, Krishnareddy S, Green PH. Celiac disease - autoimmunity, infectious links and the microbiome. Book: Eslick GD (Ed.) Gastrointestinal Diseases and Their Associated Infections Elsevier, Amsterdam, Netherlands (2019) 201-216.
Nobel YR, Shen B. Combined Endoscopic Stricturotomy and Balloon Dilation of Strictureplasty-Site Stricture in Jejunal Crohn’s Disease. ACG Case Reports Journal (2020) 7:e00401.
Nobel YR, Lodish MB, Raygada M, Del Rivero J, Faucz FR, Abraham SB, Lyssikatos C, Belyavskaya E, Stratakis CA, Zilbermint M. Pseudohypoaldosteronism type 1 due to novel variants of SCNN1B gene. Endocrinology, Diabetes, and Metabolism Case Reports (2016) 2016:150104.